11 min listen
E42: SENSCIS - Nintedanib for Systemic Sclerosis ILD
E42: SENSCIS - Nintedanib for Systemic Sclerosis ILD
ratings:
Length:
16 minutes
Released:
Jul 25, 2019
Format:
Podcast episode
Description
This week I'll discuss an important paper in systemic sclerosis, the recent SENSCIS trial that compared 150mg nitedanib to placebo. I wind up coming down pretty hard on this drug; I think it's hype has vastly outpaced its utility. Get the paper itself at ebrheum.com and follow me on @ebrheum to give feedback!
Released:
Jul 25, 2019
Format:
Podcast episode
Titles in the series (87)
E13: Withdrawing HCQ in SLE: Short podcast today on an old RCT addressing the utility of hydroxychloroquine (plaquenil) in lupus. It's an oldie but goodie and one that I enjoyed talking about. by The Evidence Based Rheumatology Podcast